Procurement teams evaluating HCG (5000IU / 10000IU) in Growth Research programs can use this spec alignment brief before requesting a quote on sulanpeptide.vip.
HCG, short for human chorionic gonadotropin, is a glycoprotein hormone used in laboratory research on gonadotropin signaling, receptor-binding models, endocrine pathway studies, and protein-hormone activity assays.
Endocrine assay development papers use hCG as reference standard for CG receptor pharmacology and pregnancy diagnostic kit calibration—not therapeutic protocols. Human chorionic gonadotropin activates LH/CG receptors on Leydig and luteal cells, stimulating cAMP-mediated steroidogenesis in endocrine research models.
Glycoprotein heterodimer structure (α and β subunits) is verified by mass spectrometry in quality-focused research material characterization. Testosterone secretion from primary Leydig cell cultures and receptor-binding displacement assays quantify gonadotropin bioactivity in research lots.
Principal investigators should sign off HCG SKUs only after mechanism fit is documented in the study protocol. Spec alignment: Enter exact strength notation (5000IU / 10000IU) in procurement systems—do not round kit counts.
Side-by-side review of specification table, vial label, and COA prevents release errors for HCG.
Catalog identifiers for HCG: CAS 9002-61-3, Formula: -. MW Approx. 36.7 kDa, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Dose planning for HCG should state mass (5000IU / 10000IU) or molarity derived from catalog molecular weight.
Publication methods should list Cat No. and mg strength for HCG to support reproducibility.
Molecular identifiers for HCG—CAS 9002-61-3, molecular weight, and formula when listed—should appear on internal sample labels alongside Cat No. Publications citing HCG should include these fields for reproducibility in Growth Research journals. Format selection for HCG affects reconstitution math and aliquot planning. Compare available vial strengths on sulanpeptide.vip against protocol dose ranges before leadership approves a SKU; changing strength mid-study complicates comparability.
Side-by-side review of catalog specification table, quote confirmation, vial label, and COA prevents release errors for HCG. QA sign-off should reference all four documents in the batch record. Purity target ≥ 99.0% on the catalog is a specification goal. Release criteria for HCG should state whether the lot COA must meet or exceed that threshold for your Growth Research assay type.
Specification alignment for HCG requires copying exact kit notation (5000IU / 10000IU) into ERP or LIMS systems. Rounding “10mg×10 vials” to “100mg total” causes mismatches when COA lists per-vial strength and suppliers ship multi-vial kits.
Purity target ≥ 99.0% on the catalog is a specification goal. Release criteria for HCG should state whether the lot COA must meet or exceed that threshold for your Growth Research assay type. Specification alignment for HCG requires copying exact kit notation (5000IU / 10000IU) into ERP or LIMS systems. Rounding “10mg×10 vials” to “100mg total” causes mismatches when COA lists per-vial strength and suppliers ship multi-vial kits.
Side-by-side review of catalog specification table, quote confirmation, vial label, and COA prevents release errors for HCG. QA sign-off should reference all four documents in the batch record.
HCG from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.